Sanjeev A. Vasudevan, MD
Department or Service
- Texas Medical Center
- Specialty Care
Attending Surgeon, Pediatric Surgery Service
Co-Director, Liver Tumor Program
Texas Children's Hospital
Associate Professor, Surgery and Pediatrics, Baylor College of Medicine
|Baylor College of Medicine||fellowship||Pediatric Surgery||2011|
|Baylor College of Medicine||residency||General Surgery||2009|
|Emory University School of Medicine||medical school||Doctor of Medicine||2001|
Dr. Vasudevan is a pediatric surgeon who specializes in pediatric surgical oncology. In addition to performing general neonatal and pediatric surgery, he is a member of the Surgical Oncology Program at Texas Children's Hospital and is actively involved with taking care of patients with hepatoblastoma, hepatocellular carcinoma, embryonal sarcoma of the liver, benign tumors of the liver (mesenchymal hamartoma, hemangiomas, FNH, cysts), neuroblastoma, renal tumors (Wilms tumor, clear cell sarcoma, renal cell carcinoma), sarcomas (rhabdomyosarcoma, nonrhabdo-soft tissue sarcoma, malignant peripheral nerve sheath tumors, synovial cell sarcoma), and rare gastrointestinal (colon, rectal, pancreatic, bile duct cancers) and thoracic (pleuropulmonary-blastoma, sarcomas of the lung, endobronchial carcinoid, germ cell tumors, thymus) cancers. Dr. Vasudevan specializes in complex hepatobiliary surgery, in particular, extreme liver resections for cancer (trisegmentectomy, multifocal disease, etc.), complex “high-risk” neuroblastoma resections of the chest and abdomen, and complex chest wall, thoracic/abdominal, and extremity sarcoma resections.
Dr. Vasudevan has organized the first ever Surgical Oncology Program at Texas Children’s Hospital which brings together the brightest and most gifted surgical oncologists in all subspecialities of surgery with the one common goal of giving children with cancer the BEST multi-disciplinary surgical oncologic care possible. Dr. Vasudevan is the surgical lead of the Texas Children’s Liver Tumor Program and is actively involved in the liver cancer committee of the Children’s Oncology Group. He was instrumental in helping to organize and write the newest international pediatric liver tumor trial (PHITT trial, AHEP1531) due to open in the spring of 2018. Dr. Vasudevan serves as the surgical vice-chair for the PHITT trial.
Dr. Vasudevan’s clinical program in Surgical Oncology has motivated his research effort. He serves as the director of the Pediatric Surgical Oncology Laboratory which focuses on “personalized medicine” techniques to find novel therapies to treat “high-risk” hepatoblastoma and neuroblastoma (see Research Statement for details).
Dr. Vasudevan is certified by the American Board of Surgery in General Surgery and in Pediatric Surgery.
American Board of Pediatrics
American Board of Surgery, Pediatric Surgery
|American Association for Cancer Research (AACR)||Associate Member|
|American College of Surgeons||Resident and Associate Society Member|
|Phi Beta Kappa||Member|
Dr. Vasudevan is the director of the Pediatric Surgical Oncology Laboratory that focuses on finding targeted therapies for pediatric solid tumors, in particular, hepatoblastoma, hepatocellular carcinoma and neuroblastoma. Dr. Vasudevan’s lab is currently focusing on the mechanisms behind vascular invasion and metastasis in heptoblastoma and has received grant funding from the Macy Easom Cancer Research Foundation for this work.
He is actively involved with collecting patient tumor tissues for cell line and patient-derived xenograft development in order to develop a pipeline for “personalized medicine”. The primary goal of the Pediatric Surgical Oncology Laboratory is to validate multiple targets in order to find novel and less toxic, therapeutic agents to improve outcomes for children with solid tumors. Dr. Vasudevan’s lab also focuses on developing new intraoperative imaging techniques to make surgical oncology procedures safer and more effective.
View All Publications: